Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interferon for secondary progressive multiple sclerosis: a systematic review

5 Sept 2012

Abstract excerpt

Abstract The human serine protease TMPRSS2 gene is involved in the priming of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins being one of the possible targets for COVID-19 therapy. TMPRSS2 gene is possibly co-expressed with SARS-CoV-2 cell receptor genes ACE2 and BSG, but only TMPRSS2 demonstrates tissue-specific expression in alveolar cells according to single cell RNA sequencing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Sclerosis Research Studies
Share to Neuroinflammation and Neurodegeneration Mechanisms
Share to Peripheral Neuropathies and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22952326
DOI: 10.1136/jnnp-2012-303291

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interferon for secondary progressive multiple sclerosis: a systematic reviewPMID 22952326Read ↗

Structural variability, expression profile and pharmacogenetics properties of TMPRSS2 gene as a potential target for COVID-19 therapySemantic proximity Read ↗

Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy.Semantic proximity Read ↗

ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.Semantic proximity Read ↗

The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistanceSemantic proximity Read ↗

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosisSemantic proximity Read ↗

TMPRSS2 Transcriptional Inhibition as a Therapeutic Strategy for COVID-19 <strong> </strong>Semantic proximity Read ↗

Therapeutic Targets for Multiple System AtrophySemantic proximity Read ↗

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosisSemantic proximity Read ↗

The Impact of Sphinogosine-1-Phosphate Receptor Modulators on COVID-19 and SARS-CoV-2 VaccinationSemantic proximity Read ↗

Pharmacogenetics of multiple sclerosisSemantic proximity Read ↗

Whole transcriptome analysis of multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive casesSemantic proximity Read ↗

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.